Gonadotropin-releasing hormone analogue for premenopausal women with breast cancer

JAMA

Volumn 306, Issue 16, 2011, Pages 1760-

  Loibl, Sibylle ^a   Gerber, Bernd ^a  

^a German Breast Group   (Germany)

Author keywords

[No Author keywords available]

Indexed keywords

ANTINEOPLASTIC AGENT; ESTROGEN RECEPTOR; GONADORELIN DERIVATIVE; GOSERELIN; PROGESTERONE RECEPTOR; TAMOXIFEN; LUTEOLYTIC AGENT; TRIPTORELIN;

AMENORRHEA; BREAST CANCER; CLINICAL TRIAL (TOPIC); COHORT ANALYSIS; EARLY MENOPAUSE; FEMALE; FEMALE FERTILITY; HUMAN; LETTER; MENSTRUATION; OVARY FUNCTION; POST HOC ANALYSIS; PREMENOPAUSE; PRIORITY JOURNAL; RISK REDUCTION; TREATMENT OUTCOME; BREAST TUMOR; CHEMICALLY INDUCED DISORDER; DRUG EFFECT; FEMALE INFERTILITY; MENOPAUSE; NOTE; PREMATURE OVARIAN FAILURE;

ANTINEOPLASTIC AGENTS; BREAST NEOPLASMS; FEMALE; HUMANS; INFERTILITY, FEMALE; LUTEOLYTIC AGENTS; MENOPAUSE; PRIMARY OVARIAN INSUFFICIENCY; TRIPTORELIN;

EID: 80054883343     PISSN: 00987484     EISSN: 15383598     Source Type: Journal    
DOI: 10.1001/jama.2011.1516     Document Type: Letter

References (4)

1. Del Mastro L, Boni L, Michelotti A, et al. Effect of the gonadotropin-releasing hormone analogue triptorelin on the occurrence of chemotherapy-induced early menopause in premenopausal womenwith breast cancer: a randomized trial. JAMA. 2011;306(3):269-276.
2. Leonard RC, Adamson D, Anderson R, et al. The OPTION trial of adjuvant ovarian protection by goserelin in adjuvant adjuvant chemotherapy for early breast cancer [abstract]. J Clin Oncol. 2010;28(suppl):15S.
3. Sverrisdottir A, Nystedt M, Johansson H, Fornander T. Adjuvant goserelin and ovarian preservation in chemotherapy treated patients with early breast cancer: results from a randomized trial. Breast Cancer Res Treat. 2009;117(3):561-567.
4. Gerber B, von Minckwitz G, Stehle H, et al.; German Breast Group Investigators. Effect of luteinizing hormone-releasing hormone agonist on ovarian function after modern adjuvant breast cancer chemotherapy: the GBG 37 ZORO study. J Clin Oncol. 2011;29(17):2334-2341.